TransMedics Group Inc (TMDX)
Cash conversion cycle
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 116.71 | 126.04 | 158.72 | 184.46 | 221.21 | 238.47 | 235.11 | 266.82 | 335.69 | 448.18 | 573.53 | 595.80 | 588.63 | 490.65 | 503.07 | 483.77 | 556.17 | 484.57 | 402.29 | 420.27 |
Days of sales outstanding (DSO) | days | 82.02 | 82.57 | 100.73 | 96.04 | 115.41 | 114.82 | 118.32 | 107.83 | 112.09 | 92.10 | 109.47 | 71.57 | 53.67 | 76.44 | 107.27 | 97.72 | 93.13 | 66.88 | 84.61 | 101.42 |
Number of days of payables | days | 29.39 | 33.73 | 30.16 | 53.03 | 72.13 | 54.89 | 42.48 | 43.26 | 55.66 | 146.53 | 100.68 | 266.68 | 106.17 | 90.12 | 54.86 | 48.89 | 33.33 | 143.65 | 172.09 | 271.55 |
Cash conversion cycle | days | 169.34 | 174.87 | 229.28 | 227.47 | 264.49 | 298.39 | 310.96 | 331.39 | 392.12 | 393.75 | 582.32 | 400.69 | 536.13 | 476.98 | 555.48 | 532.60 | 615.97 | 407.79 | 314.80 | 250.15 |
September 30, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 116.71 + 82.02 – 29.39
= 169.34
TransMedics Group Inc's cash conversion cycle has shown fluctuations over the past years, ranging from as low as 169.34 days to as high as 582.32 days. The cash conversion cycle represents the time it takes for the company to convert its investments in inventory and other resources into cash inflows from sales.
A lower cash conversion cycle is generally favorable as it indicates that the company is able to efficiently manage its working capital and convert its resources into cash quickly. On the other hand, a higher cash conversion cycle may suggest inefficiencies or challenges in the management of inventory, receivables, and payables.
TransMedics' cash conversion cycle has shown some volatility, which could be attributed to various factors such as changes in sales volume, inventory management practices, and payment terms with suppliers and customers. It is important for the company to closely monitor and optimize its cash conversion cycle to improve liquidity, profitability, and overall financial performance.
Peer comparison
Sep 30, 2024